Roadmap
2023 – Company foundation
Official incorporation of Rhizopharm, based in Valencia, focused on applied root research and pharmaceutical biotechnology.
2024 – Launch of international program
Agreement signed with Chulalongkorn University and Leapdelab (Thailand) for the cultivation of Cannabis sativa and Pueraria mirifica.
2024 – Start of cultivation in Spain
Hydroponic and aeroponic cultivation of Olea europaea, Astragalus membranaceus, Withania somnifera (ashwagandha), and Valeriana officinalis (valerian).